Opthea is a clinical-stage biotech firm developing Sozinibercept, targeting VEGF-C and VEGF-D for wet AMD, with Phase 3 results due in 2025. Read more here.
Most people should have a regular eye exam every couple of years. If you're older than 65 or have certain conditions, you may need more frequent checks. (Photo Credit: iStock/Getty Images.) ...